Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients Wtih Glaucoma or Ocular Hypertension

Phase 3CompletedNCT00332072

Allergan541 enrolled

Overview

The purpose of this study is to assess the safety and efficacy of Bimatoprost/Timolol Fixed Combination in the treatment of glaucoma or ocular hypertension

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

541

Conditions

Ocular Hypertension

Interventions

bimatoprost/timolol fixed combinationDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Clinical diagnosis of ocular hypertension or chronic glaucoma in both eyes * Patient needs IOP-lowering drug in both eyes Exclusion Criteria: * Uncontrolled medical condition * Contraindication to beta-adrenoceptor antagonist therapy

Locations (1)

Unnamed facility

Ogden, Utah, United States

Outcomes

Primary Outcomes

IOP

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.